Back to dashboard
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
≈ Figures for the value of trade may not add up due to rounding.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade ≈ | Shares remaining |
|---|---|---|---|---|---|---|
| 7 August 2026 | ORBIMED ADVISORS LLCInvestment Management Company | Buy Regular purchase transaction | 1,666,667 | $18.00 | $30,000,006.00 | 11,901,826 |
| 7 August 2026 | FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 1,920,000 | $18.00 | $34,560,000.00 | 11,640,546 |
| 7 August 2026 | AH BIO FUND IV LPVenture Capital | Buy Regular purchase transaction | 1,100,000 | $18.00 | $19,800,000.00 | 10,232,420 |
| 7 August 2026 | FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 1,680,000 | $18.00 | $30,240,000.00 | 10,185,478 |
| 7 August 2026 | Travis MurdochChairman/CEO | Buy Regular purchase transaction | 83,333 | $18.00 | $1,499,994.00 | 2,940,670 |
| 7 August 2026 | Christopher A (Chris) ViehbacherChairman of the Board | Buy Regular purchase transaction | 83,333 | $18.00 | $1,499,994.00 | 609,519 |
| 7 August 2026 | David I MalekDirector | Buy Regular purchase transaction | 4,166 | $18.00 | $74,988.00 | 533,845 |
| 7 August 2026 | James Paul RickeyCFO | Buy Regular purchase transaction | 27,777 | $18.00 | $499,986.00 | 520,927 |
| 7 August 2026 | Michele A AndersonChief Level Officer | Buy Regular purchase transaction | 1,111 | $18.00 | $19,998.00 | 332,161 |
| 7 August 2026 | ORBIMED ADVISORS LLCInvestment Management Company | Buy Regular purchase transaction | 273,333 | $18.00 | $4,919,994.00 | 273,333 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade ≈ | Shares remaining |
|---|---|---|---|---|---|---|
| 7 August 2026 | FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 1,920,000 | $18.00 | $34,560,000.00 | 11,640,546 |
| 7 August 2026 | FORBION GROWTH OPPORTUNITIES FUND III COOPERATIEF UAVenture Capital | Buy Regular purchase transaction | 1,680,000 | $18.00 | $30,240,000.00 | 10,185,478 |
| 7 August 2026 | ORBIMED ADVISORS LLCInvestment Management Company | Buy Regular purchase transaction | 1,666,667 | $18.00 | $30,000,006.00 | 11,901,826 |
| 7 August 2026 | AH BIO FUND IV LPVenture Capital | Buy Regular purchase transaction | 1,100,000 | $18.00 | $19,800,000.00 | 10,232,420 |
| 7 August 2026 | ORBIMED ADVISORS LLCInvestment Management Company | Buy Regular purchase transaction | 273,333 | $18.00 | $4,919,994.00 | 273,333 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.